Page last updated: 2024-11-03

propentofylline and Hypoglycemia

propentofylline has been researched along with Hypoglycemia in 1 studies

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research Excerpts

ExcerptRelevanceReference
"Propentofylline is a novel neuroprotective agent that has been shown to act as an adenosine transport inhibitor as well as an adenosine receptor antagonist."1.29Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices. ( Fredholm, BB; Lindström, K; Wallman-Johansson, A, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fredholm, BB1
Lindström, K1
Wallman-Johansson, A1

Other Studies

1 other study available for propentofylline and Hypoglycemia

ArticleYear
Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices.
    Journal of neurochemistry, 1994, Volume: 62, Issue:2

    Topics: Adenosine; Animals; Biological Transport; Electric Stimulation; Hippocampus; Hypoglycemia; Hypoxia;

1994